Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 69, Issue 23, 2006, Pages 2071-2082

  Kim, Dong Hyun ^a   Yoo, Hwan Soo ^a   Lee, Yong Moon ^a   Kie, Jeong Hae ^b   Jang, Soyong ^c   Oh, Seikwan ^c  

^a Chungbuk National University   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FUMONISIN B1; PHOSPHATE; SPHINGANINE; SPHINGANINE 1 PHOSPHATE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE ACYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HISTOPATHOLOGY; KIDNEY TUBULE NECROSIS; LIVER INJURY; LIVER TOXICITY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING;

ANIMALS; BIOLOGICAL MARKERS; FUMONISINS; KIDNEY; LIVER; MALE; MICE; MICE, INBRED ICR; OXIDOREDUCTASES; PREDICTIVE VALUE OF TESTS; SPHINGOSINE;

ANIMALIA; SPHINGOIDEA;

EID: 33750282535     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390600746215     Document Type: Article

References (39)

1. Bermudez, A. J., Ledoux, D. R., Turk, J. R., and Rottinghaus, G. E. 1996. The chronic effects of Fusarium moniliforme culture material, containing known levels of fumonisin B1, in turkeys. Avian Dis. 40:231-235.
2. Brown, T. P., Rottinghaus, G. E., and Williams, M. E. 1992. Fumonisin mycotoxicosis in broilers: performance and pathology. Avian Dis. 36:450-454.
3. Carratu, M. R., Cassano, T., Coluccia, A., Borracci, P., and Cuomo, V. 2003. Antinutritional effects of fumonisin B1 and pathophysiological consequences. Toxicol. Lett. 140:459-463.
4. Dragon, Y. P., Bidlack, W. R., Cohen, S. M., Goldsworthy, T. L., Hard, G. C., Howard, P. C., Riley, R. T., and Voss, K. A. 2001. Implication of apoptosis for toxicity, carcinogenicity, and risk assessment: Fumonisin B1 as an example. Toxicol. Sci. 61:6-17.
5. Enongene, E. N., Sharma, R. P., Bhandari, N., Voss, K. A., and Riley, R. T. 2000. Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1. Food Chem. Toxicol. 38:793-799.
6. Gopee, N. V., and Sharma, R. P. 2003. Sphingoid bases and their phosphates: Transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity. Toxicology 187:239-250.
7. Gumprecht, L. A., Beasley, A. R., Weigel, R. M., Parker, H. M., Tumbleson, M. E., Bacon, C. W., Meredith, F. L., and Haschek W. M. 1998. Development of fumonisin-induced hepatotoxicity and pulmonary edema in orally dosed swine: Morphological and biochemical alterations. Environ. Toxicol. Pathol. 26:777-788.
8. Haschek, W. H., Gumprecht, L. A., Smith, G., Tumbleson, M. E., and Constable, P. D. 2001. Fumonisin toxicosis in swine: An overview of porcine pulmonary edema and current perspectives. Environ. Health Pesrpect. 109:251-257.
9. He, Q., Bhandari, N., and Sharma, R. P. 2002. Fumonisin B1 alters sphingolipid metabolism and tumor necrosis factor α expression in heart and lung of mice. Life Sci. 71:2015-2023.
10. Hla, T., Lee, M.-J, Ancellin, N., Liu, C. H., Thangada, S., Thompson, B. D., and Kluk, M. 1999. Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochem. Pharmacol. 58:201-207.
11. Howard, P. C., Couch, L. H., Patton, R. E., Eppley, R. M., Doerge, D. R., Churchwell, M. I., Marques, M. M., and Okerberg, C. V. 2002. Comparison of the toxicity of several fumonisin derivatives in a 28-day feeding study with female B6C3F1 mice. Toxicol. Appl. Pharmacol. 185:153-165.
12. Iwata, M., Herrington, J., and Zager, R. A. 1995. Sphingosine: A mediator of acute renal tubular injury and subsequent cytoresistance. Proc. Natl. Acad. Sci. USA 92:8970-8974.
13. Linn, S. C., Kim, H. S., Keane, E. M., Andras, L. M., Wang, E., and Merrill, A. H., Jr. 2001. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem. Soc. Trans. 29:831-835.
14. Mathur, S., Constable, P. D., Eppley, R. M., Tumbleson, M. E., Smith, G. W., Tranquilli, W. J., Morin, D. E., and Haschek, W. M. 2001a. Fumonisin B1 increases serum sphinganine concentration but does not alter serum sphingosine concentration or induce cardiovascular changes in milk-fed calves. Toxicol. Sci. 60:379-384.
15. Mathur, S., Constable, P. D., Eppley, R. M., Waggoner, A. L., Tumbleson, M. E., and Haschek, W. M. 2001b. Fumonisin B1 is hepatotoxic and nephrotoxic in milk-fed calves. Toxicol. Sci. 60:385-396.
16. Merrill, A. H., Jr. 1991. Cell regulation by sphingosine and more complex sphingolipids. J. Bioenerg. Biomembr. 23:83-103.
17. Merrill, A. H., Jr., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., and Wang, E. 1997. Sphingolipids-the enigmatic lipid class biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142:208-225.
18. Min, J. K., Yoo, H. S., Lee, E. Y., Lee, W. J., and Lee, Y. M. 2002. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal. Biochem. 303:167-175.
19. Nair, M. G. 1998. Fumonisins and human health. Ann. Trop. Paediatr. 18:S47-S52.
20. Norred, W. P., Plattner, R. D., Dombrink-Kurtzman, M. A., Meredith, F. I., and Riley, R. T. 1997. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: Specificity of the response and structure-activity relationships. Toxicol. Appl. Pharmacol. 147:63-70.
21. Qiu, M., and Liu, X. 2001. Determination of sphinganine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1. Food Addit. Contam. 18:263-269.
22. Riley, R. T., An, N. H., Showker, J. L., Yoo, H.-S., Norred, W. P., Chamberlain, W. J., Wang, E., Merrill, A. H., Jr., Motelin, G., Beasley, V. R., and Haschek, W. M. 1993. Alteration of tissue and serum sphinganine to sphingosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol. Appl. Pharmacol. 118:105-112.
23. Riley, R. T., Hinton, D. M., Chamberlain, W. J., Bacon, C. W., Wang, E., Merrill, A. H., Jr., and Voss, K. A. 1994. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: A new mechanism of nephrotoxicity. J. Nutr. 124:594-603.
24. Rotter, B. A., Thompson, B. K., Prelusky, D. B., Trenholm, H. L., Stewart, B., Miller, J. D., and Savard, M. E. 1996. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: Growth and clinical parameters. Nat. Toxins 4:42-50.
25. Skrzypek, M. S, Nagiec, M. M, Lester, R. L., and Dickson, R. C. 1999. Analysis of phosphorylated sphingolipid long-chain bases reveals potential roles in heat stress and growth control in Saccharomyces. J. Bacteriol. 181:1134-1140.
26. Smith, G. W., Constable, P. D., Eppley, R. M., Tumbleson, M. E., Gumprecht, L. A., and Haschek-Hock, W. M. 2000. Purified fumonisin B1 decreases cardiovascular function but does not alter pulmonary capillary permeability in swine. Toxicol. Sci. 56:240-249.
27. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Llenk, D. C. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
28. Solfrizzo, M., Avantaggiato, G., and Visconti, A. 1997. Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure. J. Chromatogr. B Biomed. Sci. Appl. 692:87-93.
29. Spiegel, S. 1999. Sphingosine-1-phosphate: A prototype of a new class of second messenger. J. Leukocyte Biol. 65:341-344.
30. Tran, S. T., Bailly, J. D., Tardieu, D., Durand, S., Benard, G., and Guerre, P. 2003. Sphinganine to sphingosine ratio and predictive biochemical markers of fumonisin B1 exposure in ducks. Chem. Biol. Interact. 146:61-72.
31. Tsunoda, M., Sharma, R. P., and Riley, R. T. 1998. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/C mice. J. Biochem. Mol. Toxicol. 12:281-289.
32. Turner, P. C., Nikiema, P., and Wild, C. P. 1999. Fumonisin contamination of food: Progress in development of biomarkers to better assess human health risks. Mutat. Res. 443:81-93.
33. Van Veldhoven, P. P., and Mannaerts, G. P. 1991. Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver. J. Biol. Chem. 266:12502-12507.
34. Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T., and Merrill, A. H., Jr. 1991. Inhibition of sphingolipid biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266:14486-14490.
35. Wang, E., Ross, P. F., Wilson, T. M., Riley, R. T., and Merrill, A. H., Jr. 1992. Alteration of serum sphingolipids upon dietary exposure of ponies to fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr. 122:1706-1716.
36. Yatomi, Y., Ruan, F., Hakomori, S., and Igarashi, Y. 1995. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86:193-202.
37. 1 cells. Toxicol. Appl. Pharmacol. 138:211-218.
38. Yoo, H., Norred, W. P., Showker, J., and Riley, R. T. 1996. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicol. Appl. Pharmacol. 114:9-15.
39. Yu, C. H., Lee, Y. M., Yun, Y. P., and Yoo, H. S. 2001. Differential effects of fumonisin B1 on cell death in cultured cells: The significance of the elevated sphinganine. Arch. Pharm. Res. 24:136-143.